Charles River Laboratories recently shared an interesting article called “What’s Hot in 2020: Oncology”, in which they present how the zebrafish model contributes to great progresses within cancer discovery.
“The predictive and robustness of the zebrafish platform as a part of the drug development process will elucidate the value of this emerging technology. Specifically for oncology, zebrafish platforms have the potential to drive major breakthroughs as the zebrafish mimic the process of invasion and metastasis in a realistic and robust manner.” — Julia Schüler, DVM, PhD, Research Director, Discovery Oncology Charles River